[1]
Costa Leite Lucio Silva, R. and Estrin, M.A. 2022. Cardiovascular risk associated with the use of selective COX-2 inhibitors: a systematic review. Interamerican Journal of Health Sciences. 2 (Dec. 2022), 118. DOI:https://doi.org/10.59471/ijhsc2022118.